LPS,dsRNA and the interferon bridge to adaptive immune responses: Trif,Tram,and other TIR adaptor proteins

Abstract

Toll-like receptors (TLRs) expressed on antigen-presenting cells (APCs), form a critical link between innate and the adaptive immune responses. Activation of TLRs by LPS and dsRNA results in up-regulation of co-stimulatory molecules (UCM) essential for the generation of robust T-cell responses. It is now evident that type I interferons (IFNs) play an important role in UCM and in the subsequent maturation of APCs. The recently identified adaptor molecules Trif and Tram, unlike their counterparts MyD88 and MAL/Tirap, induce type I IFN via the TLR4 signaling pathway, whereas Trif appears to be the sole adaptor molecule involved in TLR3 signaling, resulting in subsequent production of type I IFN. Here, we discuss how Trif and type I IFN are involved in the optimization of APC-T cell interaction in response not only to viral but also bacterial stimuli.

Keywords

Adaptive immune responses interferon Trif Tram

References

Skidmore BJ , Chiller JM , Morrison DC , Weigle WO Immunological properties of bacterial lipopolysaccharide (Lps) — correlation between mitogenic, adjuvant, and immunogenic activities. J Immunol 1975; 114: 770—775.

Skidmore BJ , Chiller JM , Weigle WO , Riblet R. , Watson J. Immunological properties of bacterial lipopolysaccharide (Lps). 3. Genetic linkage between in vitro mitogenic and in vivo adjuvant properties of LPS . J Exp Med 1976; 143: 143—150.

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085—2088.

Spiegelberg HL , Takabayashi K. , Beck L. , Raz E.

DNA-based vaccines for allergic disease. Expert Rev

Vaccines 2002; 1: 169—177.

Spiegelberg HL , Raz E. DNA vaccines. Allergy 1999; 54 (Suppl 56): 47—48.

Jiang ZH , Koganty RR Synthetic vaccines: the role of adjuvants in immune targeting. Curr Med Chem 2003; 10: 1423—1439.

Jenkins MK , Khoruts A. , Ingulli E. et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 23—45.

Bour-Jordan H. , Blueston JA CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002 ; 22: 1—7.

Carreno BM , Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29—53.

10.

Schwartz JC , Zhang X. , Nathenson SG , Almo SC Structural mechanisms of costimulation. Nat Immunol 2002; 3: 427—434.

11.

Cella M. , Scheidegger D. , Palmer-Lehmann K. , Lane P. , Lanzavecchia A. , Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747—752.

12.

Schoenberger SP , Toes RE , van der Voort EI , Offringa R. , Melief CJ T-cell help for cytotoxic T lymphocytes is mediated by CD40—CD40L interactions. Nature 1998; 393: 480—483.

13.

Blair PJ , Riley JL , Harlan DM et al. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis . J Exp Med 2000; 191: 651—660.

14.

Ochs HD , Hollenbaugh D. , Aruffo A. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency . Res Immunol 1994; 145: 210—215.

15.

Granucci F. , Zanoni I. , Feau S. , Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 2003; 22: 2546—2551.

16.

Hoebe K. , Du X. , Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743—748.

17.

Oshiumi H. , Matsumoto M. , Funami K. , Akazawa T. , Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003 ; 4: 161—167.

18.

Yamamoto M. , Sato S. , Mori K. et al. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169: 6668—6672.

19.

Yamamoto M. , Sato S. , Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301: 640—643.

20.

Le Bon A. , Schiavoni G. , D'Agostino G. , Gresser I. , Belardelli F. , Tough DF Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461—470.

21.

Le Bon A. , Tough DF Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002; 14: 432—436.

22.

O'Neill LA , Fitzgerald KA , Bowie AG The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003; 24: 286—290.

23.

Oshiumi H. , Sasai M. , Shida K. , Fujita T. , Matsumoto M. , Seya T. TICACM-2: a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003; 278(50): 49751—49762.

24.

Hoebe K. , Janssen E. , Kim SO et al. LPS- and dsRNA-induced upregulation of costimulatory molecules occurs via Trifdependent and Trif-independent pathways. Nat Immunol 2003; 4: 1223—1229.

25.

Alexopoulou L. , Holt AC , Medzhitov R. , Flavell RA Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732—738.

26.

Yamamoto M. , Sato S. , Hemmi H. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4: 1144—1150.

27.

Honda K. , Sakaguchi S. , Nakajima C. et al. Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA 2003; 100: 10872—10877.

28.

Diebold SS , Montoya M. , Unger H. et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424: 324—328.

29.

Isaacs A. , Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147(927): 258—267.

30.

Nagano Y. , Kojima Y. Inhibition de l'infection vaccinale par le virus homologue. C R Séances Soc Biol Fil 1958; 152: 1672—1630.

31.

Samuel CE Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778—809.

32.

Sen GC Viruses and interferons. Annu Rev Microbiol 2001; 55: 255—281.

33.

Kadowaki N. , Ho S. , Antonenko S. et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863—869.

34.

Toshchakov V. , Jones BW , Perera PY et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392—398.

35.

Hemmi H. , Kaisho T. , Takeda K. , Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003; 170: 3059—3064.

36.

Gallucci S. , Lolkema M. , Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249—1255.

37.

Le Bon A. , Etchart N. , Rossmann C. et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4: 1009—1015.

38.

Morelli AE , Larregina AT , Ganster RW et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependentpathway. J Virol 2000; 74: 9617—9628.

39.

Yoshimura S. , Bondeson J. , Foxwell BM , Brennan FM , Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, costimulatory molecules and cytokines. Int Immunol 2001; 13: 675—683.

40.

Lau JF , Horvath CM Mechanisms of type I interferon cell signaling and STAT-mediated transcriptional responses. Mt Sinai J Med 2002; 69: 156—168.

41.

Taniguchi T. , Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002 ; 14: 111—116.

42.

Taniguchi T. , Ogasawara K. , Takaoka A. , Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623—655.

43.

Zhao Z. , Qian Y. , Wald D. , Xia YF , Geng JG , Li X. IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J Immunol 2003; 170: 5674—5680.

44.

Karaghiosoff M. , Steinborn R. , Kovarik P. et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003; 4: 471—477.